CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distrib...
FDA Drug Recall #D-0364-2025 — Class II — January 31, 2025
Recall Summary
| Recall Number | D-0364-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 31, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Direct Rx |
| Location | Dawsonville, GA |
| Product Type | Drugs |
| Quantity | 477 bottles. |
Product Description
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.
Reason for Recall
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Distribution Pattern
Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID
Lot / Code Information
Lot 11SE2402, Exp Date: 11/30/2025 Lot 14NO2406, Exp Date: 12/31/2025 Lot 29OC2420, Exp Date: 11/30/2025 Lot 30SE2412, Exp Date: 11/30/2025
Other Recalls from Direct Rx
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0567-2025 | Class II | Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle... | Mar 7, 2025 |
| D-0568-2025 | Class II | Duloxetine D/R, 30 mg, 30 Caps, RX Only, Packag... | Mar 7, 2025 |
| D-0041-2025 | Class II | Ibuprofen 800mg, Generic for: Motrin, Each tabl... | Aug 9, 2024 |
| D-0508-2023 | Class II | Alprazolam C-IV, 1 mg, packaged in a) 30 Tabs p... | Mar 22, 2023 |
| D-0507-2023 | Class II | Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle, Rx... | Mar 22, 2023 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.